Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 2,000 shares at $2.96 ($6K) on 2014-06-19, disclosed to the SEC on 2014-06-19.
Open-market purchase of $6k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.96 | 800 | $2K | 39.7% |
| 2 | $2.99 | 1,000 | $3K | 50.2% |
| 3 | $3.00 | 200 | $600 | 10.1% |
| Total | $2.98 avg | 2,000 | $6K | 100% |
| Filing → |
| RXII | BUY | 2017-06-22 | $6K | — | Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |